Multidrug-resistant organisms (MDROs) are a major challenge in everyday medical practice, as they often cannot be treated with antibiotics. According to the Robert Koch Institute, there are 400,000–600,000 hospital-acquired infections in Germany annually, and 10,000–20,000 people die from them. Alternative treatments are therefore needed.